Long Noncoding RNA AFAP1-AS1, a Potential Novel Biomarker to Predict the Clinical Outcome of Cancer Patients: A Meta-Analysis

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s107188
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Meta-Analysis of the Prognostic Value of Long Non-Coding RNA AFAP1-AS1 for Cancer Patients in China

Oncotarget
Oncology
2017English

AFAP1-AS1 : A Novel Oncogenic Long Non-Coding RNA in Human Cancers

Cell Proliferation
MedicineCell Biology
2017English

The Prognostic Value of Long Noncoding RNA ZEB1-AS1 on Clinical Outcomes in Human Cancer

Journal of Cancer
Oncology
2018English

The Prognostic Role of Long Noncoding RNA CRNDE in Cancer Patients: A Systematic Review and Meta-Analysis

Neoplasma
Cancer Research
2019English

The Clinical Prognostic Value of lncRNA FAM83H-AS1 in Cancer Patients: A Meta-Analysis

Cancer Cell International
Cancer ResearchOncologyGenetics
2020English

Upregulated Long Intergenic Noncoding RNA KRT18P55 Acts as a Novel Biomarker for the Progression of Intestinal-Type Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Prognostic Significance of Long Noncoding RNA Z38 as a Candidate Biomarker in Breast Cancer

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2017English

A Meta-Analysis: The Diagnostic Values of Long Non-Coding RNA as a Biomarker for Gastric Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Panel of Seven Long Noncoding RNA as a Candidate Prognostic Biomarker for Ovarian Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy